16 Bit is a healthcare technology company based in Toronto, Canada, founded in 2017. The company specializes in developing AI-driven software as a medical device (SaMD) aimed at enhancing the quality, efficiency, and accessibility of healthcare. Its mission is to create trusted AI solutions that integrate seamlessly into clinical workflows, focusing on opportunistic screening and bone age assessment.

The company offers two primary products: Rho and Physis. Rho is an AI-enabled opportunistic screening system that identifies individuals at risk of osteoporosis using routine X-rays. It has received FDA De Novo Marketing Authorization and is licensed by Health Canada. Physis is a smart atlas for pediatric bone age assessment, providing accurate estimations crucial for diagnosing and managing growth disorders in children. 16 Bit’s solutions are designed for integration into clinical practices, targeting healthcare providers and medical institutions to improve patient outcomes and optimize healthcare delivery.